150 related articles for article (PubMed ID: 38684270)
1. Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial.
King W; Homer T; Harding C; Mossop H; Chadwick T; Abouhajar A; Vale L
BMJ Open; 2024 Apr; 14(4):e074445. PubMed ID: 38684270
[TBL] [Abstract][Full Text] [Related]
2. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
Harding C; Chadwick T; Homer T; Lecouturier J; Mossop H; Carnell S; King W; Abouhajar A; Vale L; Watson G; Forbes R; Currer S; Pickard R; Eardley I; Pearce I; Thiruchelvam N; Guerrero K; Walton K; Hussain Z; Lazarowicz H; Ali A
Health Technol Assess; 2022 May; 26(23):1-172. PubMed ID: 35535708
[TBL] [Abstract][Full Text] [Related]
3. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial.
Harding C; Mossop H; Homer T; Chadwick T; King W; Carnell S; Lecouturier J; Abouhajar A; Vale L; Watson G; Forbes R; Currer S; Pickard R; Eardley I; Pearce I; Thiruchelvam N; Guerrero K; Walton K; Hussain Z; Lazarowicz H; Ali A
BMJ; 2022 Mar; 376():e068229. PubMed ID: 35264408
[TBL] [Abstract][Full Text] [Related]
4. ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial.
Forbes R; Ali A; Abouhajar A; Brennand C; Brown H; Carnell S; Chadwick T; Eardley I; Lecouturier J; Mossop H; Pearce I; Pickard R; Thiruchelvam N; Walton K; Wilkinson J; Harding C
Trials; 2018 Nov; 19(1):616. PubMed ID: 30413181
[TBL] [Abstract][Full Text] [Related]
5. Use of methenamine hippurate to prevent urinary tract infections in community adult women: a systematic review and meta-analysis.
Bakhit M; Krzyzaniak N; Hilder J; Clark J; Scott AM; Mar CD
Br J Gen Pract; 2021 Jul; 71(708):e528-e537. PubMed ID: 34001538
[TBL] [Abstract][Full Text] [Related]
6. Methenamine hippurate compared with trimethoprim for the prevention of recurrent urinary tract infections: a randomized clinical trial.
Botros C; Lozo S; Iyer S; Warren A; Goldberg R; Tomezsko J; Sasso K; Sand P; Gafni-Kane A; Biener A; Botros-Brey S
Int Urogynecol J; 2022 Mar; 33(3):571-580. PubMed ID: 34115162
[TBL] [Abstract][Full Text] [Related]
7. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial).
Pickard R; Lam T; Maclennan G; Starr K; Kilonzo M; McPherson G; Gillies K; McDonald A; Walton K; Buckley B; Glazener C; Boachie C; Burr J; Norrie J; Vale L; Grant A; N'dow J
Health Technol Assess; 2012 Nov; 16(47):1-197. PubMed ID: 23199586
[TBL] [Abstract][Full Text] [Related]
8. Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCT.
Pickard R; Chadwick T; Oluboyede Y; Brennand C; von Wilamowitz-Moellendorff A; McClurg D; Wilkinson J; Ternent L; Fisher H; Walton K; McColl E; Vale L; Wood R; Abdel-Fattah M; Hilton P; Fader M; Harrison S; Larcombe J; Little P; Timoney A; N'Dow J; Armstrong H; Morris N; Walker K; Thiruchelvam N
Health Technol Assess; 2018 May; 22(24):1-102. PubMed ID: 29766842
[TBL] [Abstract][Full Text] [Related]
9. The resurgence of methenamine hippurate in the prevention of recurrent UTIs in women- a systematic review.
Kale S; Somani BK
Curr Opin Urol; 2023 Nov; 33(6):488-496. PubMed ID: 37337660
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with methenamine hippurate in recurrent urinary tract infection.
Nilsson S
Acta Med Scand; 1975; 198(1-2):81-5. PubMed ID: 1166827
[TBL] [Abstract][Full Text] [Related]
11. Methenamine hippurate for preventing urinary tract infections.
Lee BS; Bhuta T; Simpson JM; Craig JC
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD003265. PubMed ID: 23076896
[TBL] [Abstract][Full Text] [Related]
12. Long-term prophylaxis with methenamine hippurate in girls with recurrent urinary tract infections.
Petersen S
Acta Paediatr Scand; 1978 Sep; 67(5):597-9. PubMed ID: 358737
[TBL] [Abstract][Full Text] [Related]
13. Methenamine hippurate for preventing urinary tract infections.
Lee B; Bhuta T; Craig J; Simpson J
Cochrane Database Syst Rev; 2002; (1):CD003265. PubMed ID: 11869659
[TBL] [Abstract][Full Text] [Related]
14. Methenamine hippurate for preventing urinary tract infections.
Lee BB; Simpson JM; Craig JC; Bhuta T
Cochrane Database Syst Rev; 2007 Oct; (4):CD003265. PubMed ID: 17943785
[TBL] [Abstract][Full Text] [Related]
15. Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial.
Fisher H; Oluboyede Y; Chadwick T; Abdel-Fattah M; Brennand C; Fader M; Harrison S; Hilton P; Larcombe J; Little P; McClurg D; McColl E; N'Dow J; Ternent L; Thiruchelvam N; Timoney A; Vale L; Walton K; von Wilamowitz-Moellendorff A; Wilkinson J; Wood R; Pickard R
Lancet Infect Dis; 2018 Sep; 18(9):957-968. PubMed ID: 30037647
[TBL] [Abstract][Full Text] [Related]
16. Prevention of recurrent urinary infections in women: a comparative trial between nitrofurantoin and methenamine hippurate.
Brumfitt W; Cooper J; Hamilton-Miller JM
J Urol; 1981 Jul; 126(1):71-4. PubMed ID: 7019458
[TBL] [Abstract][Full Text] [Related]
17. Prevention of recurrent acute cystitis by methenamine hippurate: double blind controlled crossover long term study.
Cronberg S; Welin CO; Henriksson L; Hellsten S; Persson KM; Stenberg P
Br Med J (Clin Res Ed); 1987 Jun; 294(6586):1507-8. PubMed ID: 3111615
[TBL] [Abstract][Full Text] [Related]
18. Secondary prevention of recurrent urinary tract infections. Comparison of the effect of placebo, methenamine hippurate, nitrofurantoin and trimethoprim alone.
Kasanen A; Junnila SY; Kaarsalo E; Hajba A; Sundquist H
Scand J Infect Dis; 1982; 14(4):293-6. PubMed ID: 6761854
[TBL] [Abstract][Full Text] [Related]
19. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
20. Clinical effectiveness and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial.
Brittenden J; Cotton SC; Elders A; Tassie E; Scotland G; Ramsay CR; Norrie J; Burr J; Francis J; Wileman S; Campbell B; Bachoo P; Chetter I; Gough M; Earnshaw J; Lees T; Scott J; Baker SA; MacLennan G; Prior M; Bolsover D; Campbell MK
Health Technol Assess; 2015 Apr; 19(27):1-342. PubMed ID: 25858333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
